Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
MIXED(1)
2 unique interventions2 categories

Analytics

Trial Phases

Phase 12

Trial Status

Other2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT05020678Phase 1Active Not Recruiting
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Aggressive LymphomaB-cell Acute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia+7 more
StudydirectorStart date: 2021-08-20
NCT04623944Phase 1Active Not Recruiting
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
AML, AdultMDSRefractory Myelodysplastic Syndromes+1 more
StudydirectorStart date: 2020-09-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellB-cell Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma+1 more
Similarity Score9%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Aggressive LymphomaLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score7%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Aggressive LymphomaLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score7%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Related
2 trials

Shared therapeutic areas:

Aggressive LymphomaLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score7%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

Related
2 trials

Shared therapeutic areas:

Aggressive LymphomaLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score7%

Miguel Ángel Canales Albendea, MD

Hospital La Paz

Related
2 trials

Shared therapeutic areas:

Aggressive LymphomaLymphoma, Mantle-CellLymphoma, Non-Hodgkin
Similarity Score7%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMDS
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinWaldenstrom Macroglobulinemia
Similarity Score5%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score5%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05020678Phase 1StudyDirector

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Aggressive LymphomaB-cell Acute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia+7 more
Active Not Recruiting
NCT04623944Phase 1StudyDirector

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

AML, AdultMDSRefractory Myelodysplastic Syndromes+1 more
Active Not Recruiting

All 2 trials loaded